Lamotrigine ER

Lamictal XR

Strengths & Sizes

Lamotrigine ER
Lamotrigine ER

Note: product and packaging images are not actual size

  • NDC#31722-240-30
  • UPC Code331722240307
  • ImprintY31
Lamotrigine ER
Lamotrigine ER

Note: product and packaging images are not actual size

  • NDC#31722-241-30
  • UPC Code331722241304
  • ImprintY32
Lamotrigine ER
Lamotrigine ER

Note: product and packaging images are not actual size

  • NDC#31722-242-30
  • UPC Code331722242301
  • ImprintY33
Lamotrigine ER
Lamotrigine ER

Note: product and packaging images are not actual size

  • NDC#31722-243-30
  • UPC Code331722243308
  • ImprintY34
Lamotrigine ER
Lamotrigine ER

Note: product and packaging images are not actual size

  • NDC#31722-244-30
  • UPC Code331722244305
  • ImprintY35
Lamotrigine ER
Lamotrigine ER

Note: product and packaging images are not actual size

  • NDC#31722-245-30
  • UPC Code331722245302
  • ImprintY36

Indications

Lamotrigine Extended-Release Tablets are indicated for: • adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures with or without secondary generalization in patients aged 13 years and older. (1.1) • conversion to monotherapy in patients aged 13 years and older with partial-onset seizures who are receiving treatment with a single antiepileptic drug. (1.2) Limitation of use: Safety and effectiveness in patients younger than 13 years have not been established. (1.3)